 Diagnosis, Precentage in Top Five
acute leukemia, 0.02
acute lymphoblastic leukemia (all), 0.02
acute rheumatic fever, 0.06
alport syndrome, 0.06
amyloidosis, 0.14
anemia, 0.02
antiphospholipid syndrome, 0.08
antisynthetase syndrome, 0.02
anxiety or psychogenic dysphagia, 0.02
autoimmune hepatitis, 0.08
autoimmune hepatitis with multisystem involvement, 0.02
chronic myelogenous leukemia (cml), 0.02
coarctation of the aorta, 0.02
cold agglutinin disease, 0.02
congenital central hypoventilation syndrome, 0.02
congenital heart defect with pulmonary hypertension, 0.02
congenital heart disease, 0.04
congenital heart disease with complications, 0.02
congenital heart disease with secondary effects, 0.02
congestive heart failure, 0.02
costochondritis, 0.02
crest syndrome (limited scleroderma), 0.02
cyanotic congenital heart disease, 0.02
cyanotic heart disease, 0.02
cystic fibrosis, 0.24
dehydration, 0.04
dermatomyositis, 1.36
ehlers-danlos syndrome, 0.22
ehlers-danlos syndrome (vascular type), 0.04
eisenmenger syndrome, 0.06
eosinophilic esophagitis, 0.36
eosinophilic fasciitis, 0.5
eosinophilic granulomatosis with polyangiitis (churg-strauss syndrome), 0.02
eosinophilic granulomatosis with polyangiitis (egpa), 0.1
esophageal dysmotility, 0.06
esophageal stricture, 0.14
fanconi syndrome, 0.02
fibromyalgia, 0.02
fifth disease (erythema infectiosum), 0.02
fifth disease (parvovirus b19 infection), 0.02
gastroesophageal reflux disease (gerd), 0.08
gaucher disease, 0.06
gaucher's disease, 0.04
glycogen storage disease, 0.06
goodpasture syndrome, 0.02
granulomatosis with polyangiitis (wegener's granulomatosis), 0.02
hemolytic uremic syndrome, 0.02
hemophagocytic lymphohistiocytosis (hlh), 0.02
henoch-schönlein purpura, 0.12
henoch-schönlein purpura (hsp), 0.92
henoch-schönlein purpura (iga vasculitis), 0.02
henoch-schönlein purpura with atypical presentation, 0.02
hepatic involvement in a systemic inflammatory disorder, 0.02
hyperthyroidism, 0.02
hypothyroidism, 0.3
iga nephropathy, 0.04
infectious mononucleosis, 0.4
infective endocarditis, 0.24
juvenile dermatomyositis, 10.44
juvenile idiopathic arthritis, 0.46
juvenile idiopathic arthritis (jia), 4.68
juvenile idiopathic arthritis (jia) with complications, 0.02
juvenile idiopathic arthritis (jia) with raynaud's, 0.02
juvenile idiopathic arthritis (jia) with raynaud's phenomenon, 0.06
juvenile idiopathic arthritis (jia) with secondary sjögren's syndrome, 0.02
juvenile idiopathic arthritis (jia) with systemic features, 0.46
juvenile idiopathic arthritis (jia) with systemic involvement, 0.16
juvenile idiopathic arthritis (jia) with systemic onset, 0.32
juvenile idiopathic arthritis (systemic onset), 0.32
juvenile idiopathic arthritis (systemic), 0.04
juvenile idiopathic arthritis (with raynaud's phenomenon), 0.02
juvenile idiopathic arthritis (with systemic features), 0.04
juvenile idiopathic arthritis (with systemic involvement), 0.06
juvenile idiopathic arthritis with lung involvement, 0.02
juvenile idiopathic arthritis with systemic features, 0.06
juvenile idiopathic arthritis with systemic onset, 0.02
juvenile myasthenia gravis, 0.02
juvenile rheumatoid arthritis, 0.26
juvenile rheumatoid arthritis (jra), 0.5
juvenile rheumatoid arthritis (jra) with extra-articular manifestations, 0.02
juvenile rheumatoid arthritis (jra) with raynaud's phenomenon, 0.04
juvenile rheumatoid arthritis (systemic onset), 0.04
juvenile rheumatoid arthritis with systemic features (still’s disease), 0.02
juvenile rheumatoid arthritis with systemic onset, 0.02
juvenile rheumatoid arthritis with visceral involvement, 0.02
juvenile sarcoidosis, 0.02
juvenile scleroderma, 0.14
juvenile sjögren's syndrome, 0.02
juvenile systemic lupus erythematosus, 0.04
juvenile systemic lupus erythematosus (jsle), 0.1
juvenile systemic sclerosis, 2.94
juvenile systemic sclerosis (scleroderma), 0.08
kawasaki disease, 1.84
langerhans cell histiocytosis, 0.02
leukemia, 0.06
lupus (juvenile systemic lupus erythematosus), 0.06
lupus (sle), 0.04
lupus (systemic lupus erythematosus - sle), 0.32
lupus (systemic lupus erythematosus or sle), 0.02
lupus (systemic lupus erythematosus), 4.0
lupus erythematosus, 0.16
lupus nephritis, 0.02
lymphoma, 0.04
meningococcemia, 0.02
mitochondrial myopathy, 0.02
mixed connective tissue disease, 3.4
mixed connective tissue disease (mctd), 14.32
mononucleosis, 0.02
muscular dystrophy, 0.02
myasthenia gravis, 0.16
niemann-pick disease, 0.06
parvovirus b19 infection, 0.02
pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (pandas), 0.02
pediatric lupus (sle), 0.02
pediatric lupus (systemic lupus erythematosus), 0.04
pediatric rheumatoid arthritis (jia), 0.02
pediatric systemic lupus erythematosus, 0.02
pediatric systemic lupus erythematosus (sle), 0.04
pediatric vasculitis, 0.02
pheochromocytoma, 0.02
polyarteritis nodosa, 0.3
polyarteritis nodosa (pan), 0.02
polyarticular juvenile rheumatoid arthritis, 0.02
polymyositis, 0.32
polymyositis/dermatomyositis, 0.04
primary biliary cholangitis, 0.1
primary biliary cholangitis (pbc), 0.04
primary biliary cholangitis (pbc) with overlap syndrome, 0.02
primary biliary cholangitis (pbc), with overlapping autoimmune features, 0.02
primary biliary cholangitis with overlap syndrome, 0.04
primary hypertension, 0.02
primary myelofibrosis, 0.02
primary pulmonary arterial hypertension, 0.02
primary pulmonary hypertension, 0.1
primary raynaud's phenomenon with complications, 0.02
primary raynaud's phenomenon with esophageal dysmotility, 0.02
primary raynaud's phenomenon with secondary complications, 0.12
primary raynaud's phenomenon with secondary lung involvement, 0.02
primary raynaud's phenomenon with secondary organ involvement, 0.02
primary raynaud's phenomenon with secondary symptoms, 0.02
primary sjögren's syndrome, 0.16
primary sjögren’s syndrome, 0.02
psoriatic arthritis, 0.02
pulmonary arterial hypertension (pah), 0.02
pulmonary arterial hypertension (pah) secondary to connective tissue disease, 0.02
pulmonary arteriovenous malformation, 0.02
pulmonary fibrosis, 0.02
pulmonary hypertension, 0.02
raynaud's disease, 0.24
raynaud's disease with secondary complications, 0.04
raynaud's phenomenon, 1.9
raynaud's phenomenon (secondary), 0.02
raynaud's phenomenon as part of scleroderma, 0.02
raynaud's phenomenon secondary to a connective tissue disease, 0.02
raynaud's phenomenon secondary to an autoimmune condition, 0.06
raynaud's phenomenon secondary to an autoimmune disease, 0.04
raynaud's phenomenon secondary to an autoimmune disorder, 0.12
raynaud's phenomenon secondary to an underlying condition, 0.04
raynaud's phenomenon secondary to another autoimmune condition, 0.08
raynaud's phenomenon secondary to another autoimmune disorder, 0.02
raynaud's phenomenon secondary to another condition, 0.22
raynaud's phenomenon secondary to another connective tissue disorder, 0.04
raynaud's phenomenon secondary to autoimmune disease, 0.02
raynaud's phenomenon secondary to autoimmune disorder, 0.04
raynaud's phenomenon secondary to connective tissue disease, 0.16
raynaud's phenomenon secondary to connective tissue disorder, 0.02
raynaud's phenomenon secondary to other connective tissue disease, 0.02
raynaud's phenomenon with associated autoimmune disorder, 0.02
raynaud's phenomenon with associated connective tissue disorder, 0.02
raynaud's phenomenon with complications, 0.02
raynaud's phenomenon with connective tissue disease, 0.02
raynaud's phenomenon with connective tissue disorder, 0.02
raynaud's phenomenon with overlap syndrome, 0.02
raynaud's phenomenon with secondary autoimmune condition, 0.02
raynaud's phenomenon with secondary cause, 0.12
raynaud's phenomenon with secondary causes, 0.16
raynaud's phenomenon with secondary complications, 0.04
raynaud's phenomenon with secondary connective tissue disease, 0.12
raynaud's phenomenon with secondary connective tissue disorder, 0.02
raynaud's phenomenon with secondary hypertension, 0.02
raynaud's phenomenon with secondary scleroderma, 0.06
raynaud's phenomenon with secondary sclerosis, 0.02
raynaud's phenomenon with secondary sjögren's syndrome, 0.02
raynaud's phenomenon with systemic involvement, 0.02
raynaud's phenomenon with underlying cause, 0.02
raynaud's phenomenon with underlying connective tissue disease, 0.02
raynaud's syndrome, 0.02
raynaud’s phenomenon secondary to another condition, 0.02
raynaud’s phenomenon with secondary connective tissue disease, 0.02
reye's syndrome, 0.02
rheumatic fever, 4.04
rheumatoid arthritis, 0.58
rheumatoid arthritis (juvenile form), 0.06
rheumatoid arthritis (juvenile idiopathic arthritis subtype), 0.04
rheumatoid arthritis (juvenile idiopathic arthritis), 0.14
rheumatoid arthritis (juvenile), 0.02
rheumatoid arthritis (with systemic involvement), 0.02
rheumatoid arthritis with complications, 0.04
rheumatoid arthritis with extra-articular manifestations, 0.06
rheumatoid arthritis with lung involvement, 0.02
rheumatoid arthritis with raynaud's, 0.02
rheumatoid arthritis with raynaud's phenomenon, 0.02
rheumatoid arthritis with secondary raynaud's, 0.04
rheumatoid arthritis with secondary sjögren's, 0.02
rheumatoid arthritis with secondary sjögren's syndrome, 0.04
rheumatoid arthritis with systemic involvement, 0.12
rheumatoid arthritis with vasculitis, 0.04
sarcoidosis, 2.2
scleroderma, 3.42
scleroderma (juvenile localized), 0.02
scleroderma (juvenile systemic sclerosis), 0.34
scleroderma (juvenile), 0.02
scleroderma (localized or systemic), 0.04
scleroderma (localized), 0.02
scleroderma (localized/linear), 0.02
scleroderma (pediatric), 0.04
scleroderma (systemic sclerosis), 0.72
scleroderma-like esophageal dysmotility, 0.02
sepsis, 0.02
sickle cell disease, 0.02
sjogren's syndrome, 0.06
sjögren's syndrome, 7.01
sjögren's syndrome with overlap features, 0.02
sjögren’s syndrome, 0.46
still's disease, 0.04
still's disease (systemic juvenile idiopathic arthritis), 0.02
systemic juvenile idiopathic arthritis, 0.14
systemic juvenile idiopathic arthritis (sjia), 0.5
systemic juvenile idiopathic arthritis (still's disease), 0.02
systemic lupus erythematosus, 0.48
systemic lupus erythematosus (juvenile), 0.02
systemic lupus erythematosus (sle), 12.54
systemic scleroderma, 0.06
systemic sclerosis, 0.02
systemic sclerosis (juvenile scleroderma), 0.22
systemic sclerosis (juvenile), 0.06
systemic sclerosis (pediatric scleroderma), 0.02
systemic sclerosis (scleroderma), 6.45
tetralogy of fallot, 0.04
vasculitis, 0.24
vasculitis (e.g., granulomatosis with polyangiitis), 0.02
vasculitis (e.g., henoch-schönlein purpura), 0.02
vasculitis (e.g., kawasaki disease), 0.04
vasculitis (e.g., kawasaki disease, henoch-schönlein purpura), 0.02
vasculitis (e.g., polyarteritis nodosa), 0.06
viral exanthem, 0.04
viral hepatitis, 0.16
viral infection, 0.04
viral infection (e.g., epstein-barr virus), 0.1
viral infection (e.g., infectious mononucleosis), 0.02
viral infection (e.g., parvovirus b19), 0.04
viral infection (such as epstein-barr virus), 0.02
viral infection with autoimmune features, 0.02
viral meningitis with associated autoimmune response, 0.02
viral myocarditis, 0.08
wegener's granulomatosis (granulomatosis with polyangiitis), 0.02
wilson's disease, 0.12
wilson’s disease, 0.02
xerostomia, 0.02
